Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 114 entries
Sorted by: Best Match Show Resources per page
"Informed" Consent: An Audit of Informed Consent of Cesarean Section Evaluating Patient Education and Awareness.

Journal of obstetrics and gynaecology of India

Kirane AG, Gaikwad NB, Bhingare PE, Mule VD.
PMID: 26663996
J Obstet Gynaecol India. 2015 Dec;65(6):382-5. doi: 10.1007/s13224-014-0651-z. Epub 2015 Feb 15.

INTRODUCTION: Better diagnosis and early referral due to increased health care coverage have increased the cesarean deliveries at tertiary-care hospitals of India. Improvements in the health care system raise many concerns and need of cross-checking system in place to...

Cite
Kirane AG, Gaikwad NB, Bhingare PE, et al. "Informed" Consent: An Audit of Informed Consent of Cesarean Section Evaluating Patient Education and Awareness. J Obstet Gynaecol India. 2015;65(6):382-5doi: 10.1007/s13224-014-0651-z.
Kirane, A. G., Gaikwad, N. B., Bhingare, P. E., & Mule, V. D. (2015). "Informed" Consent: An Audit of Informed Consent of Cesarean Section Evaluating Patient Education and Awareness. Journal of obstetrics and gynaecology of India, 65(6), 382-5. https://doi.org/10.1007/s13224-014-0651-z
Kirane, Akhilesh G, et al. ""Informed" Consent: An Audit of Informed Consent of Cesarean Section Evaluating Patient Education and Awareness." Journal of obstetrics and gynaecology of India vol. 65,6 (2015): 382-5. doi: https://doi.org/10.1007/s13224-014-0651-z
Kirane AG, Gaikwad NB, Bhingare PE, Mule VD. "Informed" Consent: An Audit of Informed Consent of Cesarean Section Evaluating Patient Education and Awareness. J Obstet Gynaecol India. 2015 Dec;65(6):382-5. doi: 10.1007/s13224-014-0651-z. Epub 2015 Feb 15. PMID: 26663996; PMCID: PMC4666209.
Copy Download .nbib Format: NLM
CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective.

Nature clinical practice. Cardiovascular medicine

Kirtane AJ, Leon MB.
PMID: 18594550
Nat Clin Pract Cardiovasc Med. 2008 Aug;5(8):448-9. doi: 10.1038/ncpcardio1273. Epub 2008 Jul 01.

No abstract available.

Cite
Kirtane AJ, Leon MB. CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective. Nat Clin Pract Cardiovasc Med. 2008;5(8):448-9doi: 10.1038/ncpcardio1273.
Kirtane, A. J., & Leon, M. B. (2008). CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective. Nature clinical practice. Cardiovascular medicine, 5(8), 448-9. https://doi.org/10.1038/ncpcardio1273
Kirtane, Ajay J, and Leon, Martin B. "CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective." Nature clinical practice. Cardiovascular medicine vol. 5,8 (2008): 448-9. doi: https://doi.org/10.1038/ncpcardio1273
Kirtane AJ, Leon MB. CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective. Nat Clin Pract Cardiovasc Med. 2008 Aug;5(8):448-9. doi: 10.1038/ncpcardio1273. Epub 2008 Jul 01. PMID: 18594550.
Copy Download .nbib Format: NLM
Pictorial review of MRI/CT Scan in congenital temporal bone anomalies, in patients for cochlear implant.

The Indian journal of radiology & imaging

Gupta SS, Maheshwari SR, Kirtane MV, Shrivastav N.
PMID: 19881062
Indian J Radiol Imaging. 2009 Apr-Jun;19(2):99-106. doi: 10.4103/0971-3026.50825.

High-resolution CT scan (HRCT) and MRI are routinely performed prior to cochlear implant surgery. These modalities help assess the status of the inner ear structures. A few patients have significant anomalies, which need to be assessed and understood in...

Cite
Gupta SS, Maheshwari SR, Kirtane MV, et al. Pictorial review of MRI/CT Scan in congenital temporal bone anomalies, in patients for cochlear implant. Indian J Radiol Imaging. 2009;19(2):99-106doi: 10.4103/0971-3026.50825.
Gupta, S. S., Maheshwari, S. R., Kirtane, M. V., & Shrivastav, N. (2009). Pictorial review of MRI/CT Scan in congenital temporal bone anomalies, in patients for cochlear implant. The Indian journal of radiology & imaging, 19(2), 99-106. https://doi.org/10.4103/0971-3026.50825
Gupta, Santosh S, et al. "Pictorial review of MRI/CT Scan in congenital temporal bone anomalies, in patients for cochlear implant." The Indian journal of radiology & imaging vol. 19,2 (2009): 99-106. doi: https://doi.org/10.4103/0971-3026.50825
Gupta SS, Maheshwari SR, Kirtane MV, Shrivastav N. Pictorial review of MRI/CT Scan in congenital temporal bone anomalies, in patients for cochlear implant. Indian J Radiol Imaging. 2009 Apr-Jun;19(2):99-106. doi: 10.4103/0971-3026.50825. PMID: 19881062; PMCID: PMC2765183.
Copy Download .nbib Format: NLM
Spontaneous CSF otorrhoea - Presenting as conductive deafness.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Pachauri R, Nagaonkar S, Kirtane MV.
PMID: 23119854
Indian J Otolaryngol Head Neck Surg. 2002 Jan;54(1):51-4. doi: 10.1007/BF02911008.

Spontaneous CSF otorrhea specially in older age is a rare condition. Congenital inner ear malformation is one of the commonest causes in pediatric age group and either because of trauma or spontaneously it comes out into middle ear. In...

Cite
Pachauri R, Nagaonkar S, Kirtane MV. Spontaneous CSF otorrhoea - Presenting as conductive deafness. Indian J Otolaryngol Head Neck Surg. 2002;54(1):51-4doi: 10.1007/BF02911008.
Pachauri, R., Nagaonkar, S., & Kirtane, M. V. (2002). Spontaneous CSF otorrhoea - Presenting as conductive deafness. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 54(1), 51-4. https://doi.org/10.1007/BF02911008
Pachauri, Rajeev, et al. "Spontaneous CSF otorrhoea - Presenting as conductive deafness." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 54,1 (2002): 51-4. doi: https://doi.org/10.1007/BF02911008
Pachauri R, Nagaonkar S, Kirtane MV. Spontaneous CSF otorrhoea - Presenting as conductive deafness. Indian J Otolaryngol Head Neck Surg. 2002 Jan;54(1):51-4. doi: 10.1007/BF02911008. PMID: 23119854; PMCID: PMC3450696.
Copy Download .nbib Format: NLM
Giant frontoethmoid osteoma nasoendoscopic resection using intranasal drill.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Singh M, Nagaonkar S, Kirtane MV.
PMID: 23120112
Indian J Otolaryngol Head Neck Surg. 2004 Oct;56(4):324-6. doi: 10.1007/BF02974403.

Ostenmas of the paranasal sinuses are common. Most arc however asymptomatic and a chance radiographic finding. In this article we present a less invasive yet safe and effective approach to treatment. The 45° nasoettdoscopic approach using an intranasal drill...

Cite
Singh M, Nagaonkar S, Kirtane MV. Giant frontoethmoid osteoma nasoendoscopic resection using intranasal drill. Indian J Otolaryngol Head Neck Surg. 2004;56(4):324-6doi: 10.1007/BF02974403.
Singh, M., Nagaonkar, S., & Kirtane, M. V. (2004). Giant frontoethmoid osteoma nasoendoscopic resection using intranasal drill. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 56(4), 324-6. https://doi.org/10.1007/BF02974403
Singh, Meenakshi, et al. "Giant frontoethmoid osteoma nasoendoscopic resection using intranasal drill." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 56,4 (2004): 324-6. doi: https://doi.org/10.1007/BF02974403
Singh M, Nagaonkar S, Kirtane MV. Giant frontoethmoid osteoma nasoendoscopic resection using intranasal drill. Indian J Otolaryngol Head Neck Surg. 2004 Oct;56(4):324-6. doi: 10.1007/BF02974403. PMID: 23120112; PMCID: PMC3451159.
Copy Download .nbib Format: NLM
Impact of general versus epidural anesthesia on early post-operative cognitive dysfunction following hip and knee surgery.

Journal of emergencies, trauma, and shock

Mandal S, Basu M, Kirtania J, Sarbapalli D, Pal R, Kar S, Kundu KK, Sarkar U, Gupta SD.
PMID: 21633563
J Emerg Trauma Shock. 2011 Jan;4(1):23-8. doi: 10.4103/0974-2700.76829.

BACKGROUND: Post-operative cognitive dysfunction is the subtle cerebral complication temporally seen following surgery. The aim of this study was to compare the influence of either general anesthesia (GA) or epidural anesthesia (EA) on the early post-operative neurocognitive outcome in...

Cite
Mandal S, Basu M, Kirtania J, et al. Impact of general versus epidural anesthesia on early post-operative cognitive dysfunction following hip and knee surgery. J Emerg Trauma Shock. 2011;4(1):23-8doi: 10.4103/0974-2700.76829.
Mandal, S., Basu, M., Kirtania, J., Sarbapalli, D., Pal, R., Kar, S., Kundu, K. K., Sarkar, U., & Gupta, S. D. (2011). Impact of general versus epidural anesthesia on early post-operative cognitive dysfunction following hip and knee surgery. Journal of emergencies, trauma, and shock, 4(1), 23-8. https://doi.org/10.4103/0974-2700.76829
Mandal, Sripurna, et al. "Impact of general versus epidural anesthesia on early post-operative cognitive dysfunction following hip and knee surgery." Journal of emergencies, trauma, and shock vol. 4,1 (2011): 23-8. doi: https://doi.org/10.4103/0974-2700.76829
Mandal S, Basu M, Kirtania J, Sarbapalli D, Pal R, Kar S, Kundu KK, Sarkar U, Gupta SD. Impact of general versus epidural anesthesia on early post-operative cognitive dysfunction following hip and knee surgery. J Emerg Trauma Shock. 2011 Jan;4(1):23-8. doi: 10.4103/0974-2700.76829. PMID: 21633563; PMCID: PMC3097574.
Copy Download .nbib Format: NLM
ORBITA.

Circulation

Kirtane AJ.
PMID: 29789301
Circulation. 2018 Oct 23;138(17):1793-1796. doi: 10.1161/CIRCULATIONAHA.118.035331.

No abstract available.

Cite
Kirtane AJ. ORBITA. Circulation. 2018;138(17):1793-1796doi: 10.1161/CIRCULATIONAHA.118.035331.
Kirtane, A. J. (2018). ORBITA. Circulation, 138(17), 1793-1796. https://doi.org/10.1161/CIRCULATIONAHA.118.035331
Kirtane, Ajay J. "ORBITA." Circulation vol. 138,17 (2018): 1793-1796. doi: https://doi.org/10.1161/CIRCULATIONAHA.118.035331
Kirtane AJ. ORBITA. Circulation. 2018 Oct 23;138(17):1793-1796. doi: 10.1161/CIRCULATIONAHA.118.035331. PMID: 29789301.
Copy Download .nbib Format: NLM
Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer.

Future drug discovery

Khanna V, Kalscheuer S, Kirtane A, Zhang W, Panyam J.
PMID: 31448368
Future Drug Discov. 2019 Jul 01;1(1):FDD8. doi: 10.4155/fdd-2019-0005. eCollection 2019 Jul.

AIM: We previously developed two antibodies that bind to a cell surface protein, perlecan, overexpressed in triple-negative breast cancer (TNBC). The goal of this study was to investigate these antibodies as targeting ligands for nanoparticle-mediated drug delivery.METHODS: Paclitaxel-loaded poly(D,L-lactide-co-glycolide)...

Cite
Khanna V, Kalscheuer S, Kirtane A, et al. Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer. Future Drug Discov. 2019;1(1):FDD8doi: 10.4155/fdd-2019-0005.
Khanna, V., Kalscheuer, S., Kirtane, A., Zhang, W., & Panyam, J. (2019). Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer. Future drug discovery, 1(1), FDD8. https://doi.org/10.4155/fdd-2019-0005
Khanna, Vidhi, et al. "Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer." Future drug discovery vol. 1,1 (2019): FDD8. doi: https://doi.org/10.4155/fdd-2019-0005
Khanna V, Kalscheuer S, Kirtane A, Zhang W, Panyam J. Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer. Future Drug Discov. 2019 Jul 01;1(1):FDD8. doi: 10.4155/fdd-2019-0005. eCollection 2019 Jul. PMID: 31448368; PMCID: PMC6700713.
Copy Download .nbib Format: NLM
Second minimum lifetime measurements in 133Nd and 137Nd.

Physical review. C, Nuclear physics

He YJ, Hughes JR, Jenkins I, Kirwan AJ, Mullins SM, Nolan PJ, Wadsworth R, Wyss RA.
PMID: 9968033
Phys Rev C Nucl Phys. 1992 Jun;45(6):2683-2692. doi: 10.1103/physrevc.45.2683.

No abstract available.

Cite
He YJ, Hughes JR, Jenkins I, et al. Second minimum lifetime measurements in 133Nd and 137Nd. Phys Rev C Nucl Phys. 1992;45(6):2683-2692doi: 10.1103/physrevc.45.2683.
He, Y. J., Hughes, J. R., Jenkins, I., Kirwan, A. J., Mullins, S. M., Nolan, P. J., Wadsworth, R., & Wyss, R. A. (1992). Second minimum lifetime measurements in 133Nd and 137Nd. Physical review. C, Nuclear physics, 45(6), 2683-2692. https://doi.org/10.1103/physrevc.45.2683
He, et al. "Second minimum lifetime measurements in 133Nd and 137Nd." Physical review. C, Nuclear physics vol. 45,6 (1992): 2683-2692. doi: https://doi.org/10.1103/physrevc.45.2683
He YJ, Hughes JR, Jenkins I, Kirwan AJ, Mullins SM, Nolan PJ, Wadsworth R, Wyss RA. Second minimum lifetime measurements in 133Nd and 137Nd. Phys Rev C Nucl Phys. 1992 Jun;45(6):2683-2692. doi: 10.1103/physrevc.45.2683. PMID: 9968033.
Copy Download .nbib Format: NLM
Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE).

Cardiovascular revascularization medicine : including molecular interventions

Colleran R, Joner M, Cutlip D, Urban P, Maeng M, Jauhar R, Barakat M, Michel JM, Mehran R, Kirtane AJ, Maillard L, Kastrati A, Byrne RA.
PMID: 33608239
Cardiovasc Revasc Med. 2021 Jan 22; doi: 10.1016/j.carrev.2021.01.022. Epub 2021 Jan 22.

BACKGROUND/PURPOSE: A coronary stent with thromboresistant and pro-healing properties such as the polymer polyzene F-coated (COBRA PzF) stent might safely allow for a very short duration of triple therapy in patients taking oral anticoagulation (OAC) who undergo coronary stenting.METHODS:...

Cite
Colleran R, Joner M, Cutlip D, et al. Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE). Cardiovasc Revasc Med. 2021;doi: 10.1016/j.carrev.2021.01.022.
Colleran, R., Joner, M., Cutlip, D., Urban, P., Maeng, M., Jauhar, R., Barakat, M., Michel, J. M., Mehran, R., Kirtane, A. J., Maillard, L., Kastrati, A., Byrne, R. A. (2021). Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE). Cardiovascular revascularization medicine : including molecular interventions, . https://doi.org/10.1016/j.carrev.2021.01.022
Colleran, Róisín, et al. "Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE)." Cardiovascular revascularization medicine : including molecular interventions vol. (2021). doi: https://doi.org/10.1016/j.carrev.2021.01.022
Colleran R, Joner M, Cutlip D, Urban P, Maeng M, Jauhar R, Barakat M, Michel JM, Mehran R, Kirtane AJ, Maillard L, Kastrati A, Byrne RA. Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE). Cardiovasc Revasc Med. 2021 Jan 22; doi: 10.1016/j.carrev.2021.01.022. Epub 2021 Jan 22. PMID: 33608239.
Copy Download .nbib Format: NLM
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.

Journal of the American College of Cardiology

Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW.
PMID: 34763774
J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070.

BACKGROUND: Although a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.OBJECTIVES: The authors investigated the risk-benefit profile of 1-year vs ≤6-month DAPT after...

Cite
Palmerini T, Bruno AG, Redfors B, et al. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021;78(20):1968-1986doi: 10.1016/j.jacc.2021.08.070.
Palmerini, T., Bruno, A. G., Redfors, B., Valgimigli, M., Taglieri, N., Feres, F., Abizaid, A., Costa, R., Gilard, M., Morice, M. C., Hong, M. K., Kim, B. K., Jang, Y., Kim, H. S., Park, K. W., Colombo, A., Chieffo, A., Nakamura, M., Kotinkaduwa, L. N., Nardi, E., Saia, F., Gasparini, M., Rizzello, G., Weisz, G., Kirtane, A. J., Mehran, R., Witzenbichler, B., Galiè, N., & Stone, G. W. (2021). Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. Journal of the American College of Cardiology, 78(20), 1968-1986. https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini, Tullio, et al. "Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk." Journal of the American College of Cardiology vol. 78,20 (2021): 1968-1986. doi: https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070. PMID: 34763774.
Copy Download .nbib Format: NLM
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.

Journal of the American College of Cardiology

Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW.
PMID: 34763774
J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070.

BACKGROUND: Although a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.OBJECTIVES: The authors investigated the risk-benefit profile of 1-year vs ≤6-month DAPT after...

Cite
Palmerini T, Bruno AG, Redfors B, et al. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021;78(20):1968-1986doi: 10.1016/j.jacc.2021.08.070.
Palmerini, T., Bruno, A. G., Redfors, B., Valgimigli, M., Taglieri, N., Feres, F., Abizaid, A., Costa, R., Gilard, M., Morice, M. C., Hong, M. K., Kim, B. K., Jang, Y., Kim, H. S., Park, K. W., Colombo, A., Chieffo, A., Nakamura, M., Kotinkaduwa, L. N., Nardi, E., Saia, F., Gasparini, M., Rizzello, G., Weisz, G., Kirtane, A. J., Mehran, R., Witzenbichler, B., Galiè, N., & Stone, G. W. (2021). Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. Journal of the American College of Cardiology, 78(20), 1968-1986. https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini, Tullio, et al. "Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk." Journal of the American College of Cardiology vol. 78,20 (2021): 1968-1986. doi: https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070. PMID: 34763774.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 114 entries